EUCTR2019-003486-17-ES进行中（未招募）1 期
Immunogenicity and safety of a 9-valent human papillomavirus vaccine in HIV-positive women
CARMEN HIDALGO TENORIO0 个研究点目标入组 173 人开始时间: 2020年1月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 173
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •HIV-positive women patients of =18 years of age who, at the time of study inclusion were not infected simultaneously by the 16, 18 genotypes of HPV in vagina and/or anus.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 173
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-WLHIV patients who had simultaneous anal infection with the 16, 18, 31, 33, 45, 52 y 58 genotypes.
- •-WLHIV diagnosed in V0 of ASCC or anal HSIL.
- •-Active opportunist infection at the time of recruitment into the study.
- •-Cd4 count < 200 cel/uL.
- •-History of allergy to aluminium and/or yeast extract excipient.
研究者
相似试验
进行中（未招募）
不适用
Evaluation of Gardasil immunogenicity in HIV+ vs HIV- teenagers.HIV+ teenagers and young adults versus HIV-negative subjects: high-risk population for HPV-related disease.MedDRA version: 14.1Level: LLTClassification code 10063001Term: Human papilloma virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-002193-23-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)100
已完成
不适用
Evaluation of a prototype vaccine against enterotoxigenic Escherichia coli diarrhoeaEnterotoxigenic E. coli (ETEC) diarrhoeaInfections and InfestationsEnterotoxigenic Escherichia coli infectionISRCTN23764070Gothenburg University Vaccine Research Institute (GUVAX) (Sweden)60
进行中（未招募）
不适用
Comparison of vaccine effects of two different vaccines against Human Papillomavirus in HIV infected peopleEUCTR2011-001871-37-DKDepartment of Infectious Diseases - Aarhus University Hospital
进行中（未招募）
1 期
Efficacy of a vaccine with nine subgroups against human papilloma virus in HIV infected sexually active men who have sex with men.The purpose of the study is to investigate the efficacy of a new nonavalent HPV vaccine in sexually active HIV-infected MSM.MedDRA version: 18.1 Level: LLT Classification code 10063001 Term: Human papilloma virus infection System Organ Class: 100000004862MedDRA version: 18.1 Level: LLT Classification code 10071147 Term: Human papilloma virus immunization System Organ Class: 100000004865EUCTR2015-004524-65-DKDepartment of Infectious Diseases80
已完成
1 期
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.Prophylaxis against infections diseases: Diphtheria, Tetanus, B. pertussis, H. influenzae type b and hepatitis B.RPCEC00000103Center for Genetic Engineering and Biotechnology (CIGB).624